Study compares after-effects of prostatectomy, active surveillance, radiation, hormone therapy for prostate cancer
Estimates of long-term bowel, bladder, and sexual function after localized prostate cancer treatment may enable men to make informed choices about care, the authors said.
28 Jan 2020
An expert clears up issues surrounding prostate cancer screening recommendations at Internal Medicine Meeting 2022.
1 Jul 2022
Prostate-specific antigen-based screening programs in men ages 55 to 69 years may prevent approximately 1.3 deaths from prostate cancer over approximately 13 years per 1,000 men screened, as well as approximately three cases of metastatic prostate cancer per 1,000 men screened, the U.S. Preventive Services Task Force (USPSTF) found.
15 May 2018
Prostate cancer requires men to work through a multitude of treatment options, and if the patient ends up settling on active surveillance, then the internist's role is even more important moving forward.
1 Nov 2017
Surgery was associated with better survival than radiotherapy in men with non-metastatic prostate cancer, according to a large observational study with follow-up as long as 15 years.
11 Mar 2014
This free activity is recommended for physicians who have limited experience in practice assessment or are new to the health care quality improvement process, and is eligible for up to 20 CME credits and 20 Maintenance of Certification Practice Assessment points.
3 Jul 2018
This month's issue considers coverage of Internal Medicine Meeting 2022, Leadership Day in Washington, D.C., and ACP's ninth COVID-19 forum.
1 Jul 2022
The authors recommended against routine screening with this method in primary care to minimize unnecessary diagnostic testing, overdiagnosis, and overtreatment.
20 Mar 2018
Blame the rising rate of prostate cancer on better testing. Blame it on the ubiquity of the disease as men age. Just don't blame it on the pathologists. They feel bad enough.
1 Jul 2008
Data were collected from a nationwide Danish registry on tumor characteristics, drug use, primary prostate cancer therapy, comorbid conditions, and socioeconomic variables for men with incident prostate adenocarcinoma between 2000 and 2011.
5 Mar 2019